Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekert

Showing results (471-480 of 492) with videos related to

Pageof 50
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 4, 2016
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersZornitza Stark, Tiong Y Tan, Belinda Chong, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Nature Genetics|September 6, 2011
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemiaChristopher N Hahn, Chan-Eng Chong, Catherine L Carmichael, et al.
Cell|May 13, 2014
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesisJames A Rickard, Joanne A O'Donnell, Joseph M Evans, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Advanced Biology|October 9, 2023
Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug DevelopmentLindsay Tomlinson, Diane Ramsden, Sofia Batista Leite, et al.
Blood|February 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, et al.
ALTEX|April 12, 2025
Considerations from the pharmaceutical industry (IQ MPS affiliate) workshop on animal microphysiological systems and 3Rs in drug developmentPatrick J Devine, Manti Guha, Jason E Ekert, et al.
Pageof 50

Showing results (471-480 of 492) with videos related to

Sort By:
Pageof 50
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 4, 2016
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersZornitza Stark, Tiong Y Tan, Belinda Chong, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Nature Genetics|September 6, 2011
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemiaChristopher N Hahn, Chan-Eng Chong, Catherine L Carmichael, et al.
Cell|May 13, 2014
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesisJames A Rickard, Joanne A O'Donnell, Joseph M Evans, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Advanced Biology|October 9, 2023
Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug DevelopmentLindsay Tomlinson, Diane Ramsden, Sofia Batista Leite, et al.
Blood|February 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, et al.
ALTEX|April 12, 2025
Considerations from the pharmaceutical industry (IQ MPS affiliate) workshop on animal microphysiological systems and 3Rs in drug developmentPatrick J Devine, Manti Guha, Jason E Ekert, et al.
Pageof 50